# Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin With or Without Bevacizumab on Clinial Trial E-3200

> **NCT00897819** · — · COMPLETED · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 350 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **GENETIC:** DNA methylation analysis
- **GENETIC:** loss of heterozygosity analysis
- **GENETIC:** microsatellite instability analysis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00897819
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01-03
- **Primary completion:** 2008-01-30
- **Final completion:** 2008-01-30
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2017-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00897819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00897819, "Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin With or Without Bevacizumab on Clinial Trial E-3200". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00897819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*